Research Article
ACTH Treatment for Management of Nephrotic Syndrome: A Systematic Review and Reappraisal
Table 8
Summary of studies on ACTH in lupus nephritis.
| Study | N | Study protocol | Mean initial lab values | Study outcome | Complications |
| Lupus nephritis (LN) |
| Khastgir et al. [6] | 2 | Acthar gel: 80 units twice weekly for 6 months | N/A | 2 partial remissions | None | Madan et al. [2] | 2 | Acthar gel: 80 units twice weekly for 6 months | SCr: 1.0 mg/dl SrA: 1.7–1.8 g/dl Proteinuria: 8000–19890 mg/d | SCr: 0.8–1/1 mg/dl SrA: 2.4–3.3 g/dl Proteinuria: 1089–2454 mg/d 87.3% reduction in proteinuria 2 partial remissions | None | Fiechtner and Montroy [26] | 10 | Acthar gel: 80 units per day for 7–15 days | N/A | Improvement in joint and active skin problems | Edema (n = 1) | Bomback et al. [5] | 1 | Acthar gel: 40 units thrice weekly for 5 months | Proteinuria: 1340 mg/day | Proteinuria: 2290 mg/day No response | Weight gain (n = 1) |
|
|
SCr, serum creatinine; SrA, serum albumin.
|